328 related articles for article (PubMed ID: 11420306)
1. Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress.
Uemura S; Matsushita H; Li W; Glassford AJ; Asagami T; Lee KH; Harrison DG; Tsao PS
Circ Res; 2001 Jun; 88(12):1291-8. PubMed ID: 11420306
[TBL] [Abstract][Full Text] [Related]
2. High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes.
Death AK; Fisher EJ; McGrath KC; Yue DK
Atherosclerosis; 2003 Jun; 168(2):263-9. PubMed ID: 12801609
[TBL] [Abstract][Full Text] [Related]
3. Zoledronate upregulates MMP-9 and -13 in rat vascular smooth muscle cells by inducing oxidative stress.
Arun MZ; Reel B; Sala-Newby GB; Bond M; Tsaousi A; Maskell P; Newby AC
Drug Des Devel Ther; 2016; 10():1453-60. PubMed ID: 27143852
[TBL] [Abstract][Full Text] [Related]
4. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats.
Martinez ML; Rizzi E; Castro MM; Fernandes K; Bendhack LM; Gerlach RF; Tanus-Santos JE
Eur J Pharmacol; 2008 Dec; 599(1-3):110-6. PubMed ID: 18930722
[TBL] [Abstract][Full Text] [Related]
5. Exogenous Hydrogen Sulfide Attenuates Cardiac Fibrosis Through Reactive Oxygen Species Signal Pathways in Experimental Diabetes Mellitus Models.
Zheng D; Dong S; Li T; Yang F; Yu X; Wu J; Zhong X; Zhao Y; Wang L; Xu C; Lu F; Zhang W
Cell Physiol Biochem; 2015; 36(3):917-29. PubMed ID: 26088607
[TBL] [Abstract][Full Text] [Related]
6. In vivo effect of insulin to decrease matrix metalloproteinase-2 and -9 activity after arterial injury.
Guo J; Dhaliwall JK; Chan KK; Ghanim H; Al Koudsi N; Lam L; Madadi G; Dandona P; Giacca A; Bendeck MP
J Vasc Res; 2013; 50(4):279-88. PubMed ID: 23988659
[TBL] [Abstract][Full Text] [Related]
7. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.
Lin KY; Ito A; Asagami T; Tsao PS; Adimoolam S; Kimoto M; Tsuji H; Reaven GM; Cooke JP
Circulation; 2002 Aug; 106(8):987-92. PubMed ID: 12186805
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms underlying endothelial dysfunction in diabetes mellitus.
Hink U; Li H; Mollnau H; Oelze M; Matheis E; Hartmann M; Skatchkov M; Thaiss F; Stahl RA; Warnholtz A; Meinertz T; Griendling K; Harrison DG; Forstermann U; Munzel T
Circ Res; 2001 Feb; 88(2):E14-22. PubMed ID: 11157681
[TBL] [Abstract][Full Text] [Related]
9. High glucose enhance expression of matrix metalloproteinase-2 in smooth muscle cells.
Hao F; Yu JD
Acta Pharmacol Sin; 2003 Jun; 24(6):534-8. PubMed ID: 12791179
[TBL] [Abstract][Full Text] [Related]
10. Opposite effects of high glucose on MMP-2 and TIMP-2 in human endothelial cells.
Ho FM; Liu SH; Lin WW; Liau CS
J Cell Biochem; 2007 May; 101(2):442-50. PubMed ID: 17203468
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.
Eagleton MJ; Peterson DA; Sullivan VV; Roelofs KJ; Ford JA; Stanley JC; Upchurch GR
J Surg Res; 2002 May; 104(1):15-21. PubMed ID: 11971672
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase-2.
Kowluru RA; Kanwar M
Free Radic Biol Med; 2009 Jun; 46(12):1677-85. PubMed ID: 19345729
[TBL] [Abstract][Full Text] [Related]
13. Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells.
Bellosta S; Baetta R; Canavesi M; Comparato C; Granata A; Monetti M; Cairoli F; Eberini I; Puglisi L; Corsini A
Pharmacol Res; 2007 Aug; 56(2):160-7. PubMed ID: 17582780
[TBL] [Abstract][Full Text] [Related]
14. Buddleja officinalis suppresses high glucose-induced vascular smooth muscle cell proliferation: role of mitogen-activated protein kinases, nuclear factor-kappaB and matrix metalloproteinases.
Lee YJ; Kim JS; Kang DG; Lee HS
Exp Biol Med (Maywood); 2010 Feb; 235(2):247-55. PubMed ID: 20404041
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.
Wang H; Keiser JA
Circ Res; 1998 Oct; 83(8):832-40. PubMed ID: 9776730
[TBL] [Abstract][Full Text] [Related]
16. The effects of glucose-induced oxidative stress on growth and extracellular matrix gene expression of vascular smooth muscle cells.
Sharpe PC; Yue KK; Catherwood MA; McMaster D; Trimble ER
Diabetologia; 1998 Oct; 41(10):1210-9. PubMed ID: 9794110
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells.
Nagata T; Kai H; Shibata R; Koga M; Yoshimura A; Imaizumi T
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):588-93. PubMed ID: 12615664
[TBL] [Abstract][Full Text] [Related]
18. Effects of reduced β2-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice.
Xu J; Wang P; Wang T; Wang M; Chen S; Yu P; Yu D
BMC Cardiovasc Disord; 2014 Sep; 14():114. PubMed ID: 25204377
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of nobiletin, a citrus flavonoid, in the treatment of the cardiovascular dysfunction of diabetes in rats.
Parkar NA; Bhatt LK; Addepalli V
Food Funct; 2016 Jul; 7(7):3121-9. PubMed ID: 27279123
[TBL] [Abstract][Full Text] [Related]
20. Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases.
Hawkins BT; Lundeen TF; Norwood KM; Brooks HL; Egleton RD
Diabetologia; 2007 Jan; 50(1):202-11. PubMed ID: 17143608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
